# Neon Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neon-therapeutics

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Total disclosed funding: $161M
- Latest round: Series B (Dec 5, 2017)
- Investors on record: 12

## About

Founded in 2015 and based in Massachusetts, US, Neon Therapeutics, Inc. is a biotechnology company that focuses on developing therapies that target neoantigens and abnormal proteins for the treatment of cancer.

## Funding rounds

- Series B, Dec 5, 2017, $36M — Access Industries, Wellington Management, Nextech, Fidelity Investments, ArrowMark Partners, Hillhouse Investment, Casdin Capital, phs ventures, Partner Fund Management
- Series B, Jan 5, 2017, $70M — Access Industries, Wellington Management, Third Rock Ventures, Nextech, Fidelity Investments, phs ventures, Partner Fund Management
- Series A, Oct 1, 2015, $55M — Third Rock Ventures, Acces Industrie, Clal Biotechnology

## Investors

- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A, Series B
- Acces Industrie — Series A
- Clal Biotechnology (https://capitalatlas.ai/funds/clal-biotechnology) — Series A
- Access Industries (https://capitalatlas.ai/funds/access-industries) — Series B
- Wellington Management (https://capitalatlas.ai/funds/wellington-management) — Series B
- Nextech (https://capitalatlas.ai/funds/nextech) — Series B
- Fidelity Investments (https://capitalatlas.ai/funds/fidelity-investments) — Series B
- phs ventures — Series B
- Partner Fund Management — Series B
- ArrowMark Partners — Series B
- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series B
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series B